Hyderabad Telangana, India

Yedluri Siddhartha

This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yedluri Siddhartha. Retrieved from https://idiyas.com/inventor/yedluri-siddhartha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yedluri Siddhartha: Innovator in Pharmaceutical Compositions

Introduction

Yedluri Siddhartha is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions that enhance therapeutic efficacy.

Latest Patents

Siddhartha holds a patent for "Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochloride." This invention relates to pharmaceutical compositions that include trifluridine and tipiracil hydrochloride. More specifically, it focuses on a tablet composition that combines these two compounds along with one or more pharmaceutically acceptable excipients. The process for preparing such compositions is also detailed in the patent.

Career Highlights

He is currently associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His work at Natco Pharma has allowed him to contribute to innovative solutions in drug formulation and development.

Collaborations

Siddhartha has collaborated with esteemed colleagues such as Tripuraneni Rama Swamy Chowdary and Bhavanasi Krishna Murthy. These collaborations have further enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Yedluri Siddhartha's contributions to pharmaceutical compositions demonstrate his commitment to innovation in healthcare. His patent reflects a significant advancement in the formulation of effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…